Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Table 40 Percutaneous endoscopic gastrostomy/percutaneous endoscopic jejunostomy insertion
Ref. | Year | Country | Study design | n | Procedure | Medication | Relative risk |
Lee et al[123] | 2013 | South Korea | Retrospective | 40 (1625) | PEG | DAPT (ceased 4 d before) | Incidence of PPB on DAPT 2.5% |
Singh et al[98] | 2012 | United States | Retrospective | 122 (1541) | PEG | DAPT | Incidence of PPB 2.5% |
Lozoya-González et al[99] | 2012 | Mexico | Retrospective | 91 | PEG | DAPT (ceased 1-3 d before) | Incidence of PPB 0% |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408